Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. - Hutchinson,PE.; Osborne,JE.; Lear,JT.; Smith,AG.; Bowers,PW.; Morris,PN.; Jones,PW.; York,C.; Strange,RC.; Fryer,AA. (Clin Cancer Res, 2000)